HCL Revenue and Competitors
Estimated Revenue & Valuation
- HCL's estimated annual revenue is currently $2.8M per year.
- HCL's estimated revenue per employee is $101,500
Employee Data
- HCL has 28 Employees.
- HCL grew their employee count by 4% last year.
HCL's People
Name | Title | Email/Phone |
---|
HCL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.9M | 89 | -3% | N/A | N/A |
#2 | $262.3M | 1265 | 24% | $177.6M | N/A |
#3 | $331.8M | 1600 | 37% | $250M | N/A |
#4 | $63.1M | 348 | 20% | N/A | N/A |
#5 | $96.1M | 530 | 27% | N/A | N/A |
#6 | $3361.8M | 16213 | 39% | $1.7B | N/A |
#7 | $740.2M | 3570 | 9% | $196M | N/A |
#8 | $14.2M | 98 | -23% | N/A | N/A |
#9 | $46.1M | 289 | -4% | N/A | N/A |
#10 | $690.4M | 3401 | 12% | N/A | N/A |
What Is HCL?
H. C. L Technologies is an information technology and services company based out of D/91 Laxmi Nagar, New Delhi, Delhi, India.
keywords:N/AN/A
Total Funding
28
Number of Employees
$2.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HCL News
2022-04-19 - Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL ...
Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level...
2022-04-19 - Can HCL Technologies' stock make strong recovery after 3x jump in Q4 profit?
Can HCL Technologies' stock make strong recovery after 3x jump in Q4 profit? By. Amit Mudgill. , ETMarkets.com Last Updated: Apr 22, 2022, 02:14...
2022-04-19 - Why HCL Tech Management is comfortable with a 12-14% revenue guidance for
FY23
C Vijayakumar, CEO & MD, and Prateek Aggarwal, CFO, HCL Technologies, in conversation with ET Now after the announcement of the Q4 results.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.9M | 28 | 40% | N/A |
#2 | $2M | 28 | 0% | N/A |
#3 | $3.2M | 28 | -20% | N/A |
#4 | $2.8M | 28 | 0% | N/A |
#5 | $2.8M | 28 | N/A | N/A |